Literature DB >> 22442112

Kinetic expression analysis of the cluster mdv1-mir-M9-M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek's disease virus infection.

D Coupeau1, G Dambrine2,1, D Rasschaert1.   

Abstract

Marek's disease virus (GaHV-2) is an alphaherpesvirus that induces T-cell lymphoma in chickens. The infection includes both lytic and latent stages. GaHV-2 encodes three clusters of microRNAs (miRNAs) located in the internal (I)/terminal (T) repeat (R) regions. We characterized transcripts encompassing the mdv1-mir-M9-M4 and mir-M11-M1 clusters located in the IR(L)/TR(L) region, upstream and downstream from the meq oncogene, respectively. By 5'- and 3'-RACE-PCR and targeted RT-PCR, we showed that mdv1-mir-M9-M4 could be transcribed from an unspliced transcript or from at least 15 alternatively spliced transcripts covering the IR(L)/TR(L) region, encompassing the meq and vIL-8 genes and localizing the mdv1-mir-M9-M4 cluster to the first intron at the 5'-end. However, all these transcripts, whether spliced or unspliced, seemed to start at the same transcriptional start site, their transcription being driven by a single promoter, prmiRM9M4. We demonstrated alternative promoter usage for the meq and vIL-8 genes, depending on the phase of GaHV-2 infection. During the latent phase, the prmiRM9M4 promoter drove transcription of the meq and vIL-8 genes and the mdv1-mir-M9-M4 cluster in the first intron of the corresponding transcripts. By contrast, during the lytic phase, this promoter drove the transcription only of the mdv1-mir-M9-M4 cluster to generate unspliced mRNA, the meq and vIL-8 genes being transcribed principally from their own promoters. Despite the expression of meq and the mdv1-mir-M9-M4 cluster under two different transcriptional processes during the latent and lytic phases, our data provide an explanation for meq expression and mdv1-mir-M4-5P overexpression in miRNA libraries from GaHV-2-infected cells, regardless of the phase of infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442112     DOI: 10.1099/vir.0.040741-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas.

Authors:  Pu Zhao; Xiu-Jie Li; Man Teng; Lu Dang; Zu-Hua Yu; Jia-Qi Chi; Jing-Wei Su; Gai-Ping Zhang; Jun Luo
Journal:  Virus Genes       Date:  2015-02-11       Impact factor: 2.332

2.  Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

Authors:  Yuan Fang; Yuqi Zhou; Yun Zhang; Liangliang He; Chunyi Xue; Yongchang Cao
Journal:  Oncotarget       Date:  2017-12-17

Review 3.  A Tiny RNA that Packs a Big Punch: The Critical Role of a Viral miR-155 Ortholog in Lymphomagenesis in Marek's Disease.

Authors:  Guoqing Zhuang; Aijun Sun; Man Teng; Jun Luo
Journal:  Front Microbiol       Date:  2017-06-26       Impact factor: 5.640

4.  Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.

Authors:  Jun Luo; Man Teng; Xusheng Zai; Na Tang; Yaoyao Zhang; Ahmedali Mandviwala; Vishwanatha R A P Reddy; Susan Baigent; Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2020-04-20       Impact factor: 5.048

5.  Marek's Disease Virus Virulence Genes Encode Circular RNAs.

Authors:  Alexis S Chasseur; Gabrielle Trozzi; Céline Istasse; Astrid Petit; Perrine Rasschaert; Caroline Denesvre; Benedikt B Kaufer; Luca D Bertzbach; Benoît Muylkens; Damien Coupeau
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

Review 6.  Role of virus-encoded microRNAs in Avian viral diseases.

Authors:  Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2014-03-21       Impact factor: 5.048

7.  A phylogenomic analysis of Marek's disease virus reveals independent paths to virulence in Eurasia and North America.

Authors:  Jakob Trimpert; Nicole Groenke; Maria Jenckel; Shulin He; Dusan Kunec; Moriah L Szpara; Stephen J Spatz; Nikolaus Osterrieder; Dino P McMahon
Journal:  Evol Appl       Date:  2017-09-03       Impact factor: 5.183

8.  Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek's disease lymphomagenesis.

Authors:  Man Teng; Zu-Hua Yu; Pu Zhao; Guo-Qing Zhuang; Zi-Xiang Wu; Lu Dang; Hui-Zhen Li; Sheng-Ming Ma; Zhi-Zhong Cui; Gai-Ping Zhang; Run Wu; Jun Luo
Journal:  J Gen Virol       Date:  2017-05-11       Impact factor: 3.891

9.  Role of DNA Methylation and CpG Sites in the Viral Telomerase RNA Promoter during Gallid Herpesvirus 2 Pathogenesis.

Authors:  Srđan Pejaković; André Claude Mbouombouo Mfossa; Laëtitia Wiggers; Ahmed Kheimar; Damien Coupeau; Benedikt B Kaufer; Benoît Muylkens
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.